BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22504776)

  • 1. Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.
    Scheckenbach K; Wagenmann M; Freund M; Schipper J; Hanenberg H
    Klin Padiatr; 2012 Apr; 224(3):132-8. PubMed ID: 22504776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fanconi anemia pathway limits human papillomavirus replication.
    Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
    J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia.
    Kutler DI; Auerbach AD; Satagopan J; Giampietro PF; Batish SD; Huvos AG; Goberdhan A; Shah JP; Singh B
    Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):106-12. PubMed ID: 12525204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
    Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
    Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Wu T; Gluckman E; Soulier J; Surralles J; Castella M; van der Wal JE; Wennerberg J; Califano J; Velleuer E; Dietrich R; Ebell W; Bloemena E; Joenje H; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2008 Nov; 100(22):1649-53. PubMed ID: 19001603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource.
    Nguyen HT; Tang W; Webster ALH; Whiteaker JR; Chandler CM; Errazquin R; Roohollahi K; Fritzke M; Hoskins EE; Jonlin E; Wakefield L; Sullivan LB; Chen EY; Dorsman J; Brakenhoff R; Paulovich AG; Grompe M; Garcia-Escudero R; Wells SI; Smogorzewska A; Monnat RJ
    Int J Cancer; 2023 Jul; 153(1):183-196. PubMed ID: 36912284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature.
    Beckham TH; Leeman J; Jillian Tsai C; Riaz N; Sherman E; Singh B; Lee N; McBride S; Higginson DS
    Head Neck; 2019 May; 41(5):1418-1426. PubMed ID: 30633423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of human papillomavirus with Fanconi anemia promotes carcinogenesis in Fanconi anemia patients.
    Liu GB; Chen J; Wu ZH; Zhao KN
    Rev Med Virol; 2015 Nov; 25(6):345-53. PubMed ID: 25776992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.
    Lee RH; Kang H; Yom SS; Smogorzewska A; Johnson DE; Grandis JR
    Clin Cancer Res; 2021 Oct; 27(19):5168-5187. PubMed ID: 34045293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of a therapeutic trial of graduated volume and dose escalation for postoperative head and neck radiotherapy in a Fanconi anemia patient.
    Lewis LM; Tang AL; Wise-Draper TM; Myers KC; Greenberger JS; Takiar V
    Head Neck; 2020 Oct; 42(10):E16-E22. PubMed ID: 32770810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
    Amenábar JM; Torres-Pereira CC; Tang KD; Punyadeera C
    Cancer; 2019 Nov; 125(22):3936-3946. PubMed ID: 31390058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects.
    Klozar J; Tachezy R; Rotnáglová E; Košlabová E; Saláková M; Hamšíková E
    Wien Med Wochenschr; 2010 Jun; 160(11-12):305-309. PubMed ID: 20640929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.
    Roohollahi K; de Jong Y; Pai G; Zaini MA; de Lint K; Sie D; Rooimans MA; Rockx D; Hoskins EE; Ameziane N; Wolthuis R; Joenje H; Wells SI; Dorsman J
    Sci Rep; 2022 Jan; 12(1):45. PubMed ID: 34997070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi-like anemia related to a FANCM mutation.
    Encarnación JA; Cerezuela P; Español I; García MR; Manso C; De la Fuente I; Garrigós N; Viney A; Minguillon J; Surrallés J
    Eur J Med Genet; 2022 Jan; 65(1):104399. PubMed ID: 34793962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.
    Webster ALH; Sanders MA; Patel K; Dietrich R; Noonan RJ; Lach FP; White RR; Goldfarb A; Hadi K; Edwards MM; Donovan FX; Hoogenboezem RM; Jung M; Sridhar S; Wiley TF; Fedrigo O; Tian H; Rosiene J; Heineman T; Kennedy JA; Bean L; Rosti RO; Tryon R; Gonzalez AM; Rosenberg A; Luo JD; Carroll TS; Shroff S; Beaumont M; Velleuer E; Rastatter JC; Wells SI; Surrallés J; Bagby G; MacMillan ML; Wagner JE; Cancio M; Boulad F; Scognamiglio T; Vaughan R; Beaumont KG; Koren A; Imielinski M; Chandrasekharappa SC; Auerbach AD; Singh B; Kutler DI; Campbell PJ; Smogorzewska A
    Nature; 2022 Dec; 612(7940):495-502. PubMed ID: 36450981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Fanconi Anemia Patients with Head and Neck Squamous Cell Carcinoma: Israel Fanconi Registry.
    Tsur N; Frig O; Steinberg-Shemer O; Tamary H; Kurman N; Mizrachi A; Popovtzer A
    Isr Med Assoc J; 2022 Aug; 24(8):491-496. PubMed ID: 35971997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.
    Romick-Rosendale LE; Lui VWY; Grandis JR; Wells SI
    Mutat Res; 2013; 743-744():78-88. PubMed ID: 23333482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.